BackgroundWith the increasing incidence of tuberculosis (TB) and the shortcomings of existing TB vaccines to prevent TB in adults, new TB vaccines need to be developed to address the complex TB epidem
An important goal for personalized treatment is predicting response to a particular therapeutic. A drawback of biological treatment is immunogenicity and the development of antibodies directed against
Implementation of conjugate technology revolutionized the ability to effectively elicit long-lasting immune responses to bacterial capsular polysaccharides, and significantly reduced the burden of inv
